Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)

A Prospective Study on Online Adaptive Radiotherapy (ART) Using the ETHOS Linear Accelerator for Various Tumor Entities and the Feasibility of Integrating Multi-Parametric Patient Data Into the Adaptive Workflow

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The study focuses on the scientific and clinical evaluation of online adaptive radiotherapy (ART) using the Varian/SHS ETHOS treatment system. In this study, radiation treatment plans are dynamically adjusted on a daily basis over several weeks of therapy to account for anatomical shifts in either the tumour or adjacent normal tissue - a capability that has been difficult to achieve due to technical limitations. With the ETHOS accelerator, such real-time adjustments can be made based on cone beam computed tomography (CBCT). This is a prospective observational study with the primary objective of investigating the feasibility and acceptability of performing ART with ETHOS for different tumour entities. The study will also evaluate the feasibility of integrating multi-parametric data sets into the ART workflow, such as standardised electronic feedback on treatment toxicity from both patients (ePROMS) and physicians (ePRT).

Who May Be Eligible (Plain English)

Who May Qualify: - Adult patients (\>18 years) - All tumor entities with an indication for radiotherapy and/or chemoradiotherapy - Signed willing to sign a consent form Who Should NOT Join This Trial: - Pregnancy - Patients who are not capable of giving consent Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Adult patients (\>18 years) * All tumor entities with an indication for radiotherapy and/or chemoradiotherapy * Signed informed consent Exclusion Criteria: * Pregnancy * Patients who are not capable of giving consent

Treatments Being Tested

RADIATION

Online adaptive radiation therapy

Daily cone-beam CT based online adaptive radiation therapy

Locations (1)

Charité - Universitätsmedizin
Berlin, Germany